Ma J, Lu M, Quan H. From a national, centrally planned health system to a system based on the market: lessons from China. Health Affair. 2008;27(4):937–48.
Article
Google Scholar
Yip W, Hsiao WC. The Chinese health system at a crossroads. Health Affair. 2008;27(2):460–8.
Article
CAS
Google Scholar
Wagstaff A, Yip W, Lindelow M, Hsiao WC. China’s health system and its reform: a review of recent studies. Health Econ. 2009;18 Suppl 2:S7–23.
Article
PubMed
Google Scholar
National Health and Family Planning Commission of the P R China. Chinese health care and family planning statistics yearbook 2013. Beijing: Peking Union Medical College Press; 2013.
Google Scholar
Gao C, Xu F, Liu GG. Payment reform and changes in health care in China. Soc Sci Med. 2014;111:10–6.
Article
PubMed
Google Scholar
Long Q, Xu L, Bekedam H, Tang S. Changes in health expenditures in China in 2000s: has the health system reform improved affordability. Int J Equity Health. 2013;12(1):40.
Article
PubMed
PubMed Central
Google Scholar
Yip W, Hsiao W. Harnessing the privatisation of China’s fragmented health-care delivery. Lancet. 2014;384(9945):805–18.
Article
PubMed
Google Scholar
Hu S. Financing, pricing and utilisation of pharmaceuticals in China: the road to reform. Washington DC, USA: The World Bank; 2010.
Yang L, Cui Y, Guo S, Philippa B, Li B, David H. Evaluation, in three provinces, of the introduction and impact of China’s National Essential Medicines Scheme. Bull World Health Organ. 2013;91(3):184–94.
Article
Google Scholar
Tian X, Song Y, Zhang X. National Essential Medicines List and policy practice: A case study of China’s health care reform. BMC Health Serv Res. 2012;12(1):1.
Article
Google Scholar
National Health and Family Planning Commission of the P R China. The Initial Establishment of National Essential Medicine System. http://www.nhfpc.gov.cn/tigs/s9665/201109/199f32e6fa5442ffa731a51c44e1ea04.shtml. Accessed 27 Feb 2016.
Shaanxi Provincial Government. The Implementation Opinion of the Shaanxi Provincial Government on Reform in the County-level Public Hospitals. http://www.shaanxi.gov.cn/0/103/8952.htm. Accessed 27 Feb 2016
Chen W, Tang S, Sun J, Ross-Degnan D, Wagner AK. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv Res. 2010;10(1):211.
Article
PubMed
PubMed Central
Google Scholar
Jiang M, Yang S, Yan K, et al. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi Province of China. PLoS One. 2013;8(8):e70836.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 2011;28(1):63–7.
Article
PubMed
Google Scholar
Wang H, Li N, Zhu H, Xu S, Lu H, Feng Z. Prescription pattern and its influencing factors in Chinese county hospitals: A retrospective cross-sectional study. PLoS One. 2013;8(5):e63225.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yan K, Yang S, Fang Y, Zhao J, Liu J. KAP Survey of the Cognition of 377 Primary Doctors on National Essential Drug System. China Pharmacy. 2010;21(44):4209–12.
Google Scholar
Zhao W, Xu L, Wang X, et al. Knowledge, attitude and practice of township hospital doctors in Shandong Province on the national essential medicine system]. J Shandong Univ (Health Sciences). 2012;1:38.
Google Scholar
Song R, Ma J, Gao Y. Investigation and Analysis of the Cognition of Medical Staff to National Essential Medicine System in a Hospital. China Pharmacy. 2014;25(20):1841–3.
Google Scholar
Xu Y, Gao Z, Li Q, Xia S. KAP Survey of Medical Staff in Primary Institution on National Essential Medicine System in Guangzhou. China Pharmacy. 2014;25(8):688–90.
CAS
Google Scholar
National Health and Family Planning Commission of the P R China. The Number of National Medical Institutions by the end of November 2014. http://www.nhfpc.gov.cn/mohwsbwstjxxzx/s7967/201501/1e39cfd2159d426c8e46e29280dbd7f9.shtml. Accessed 27 Feb 2016.
Development of Clinical Pharmacy Services in China - China Express - Issue 4 - The University of Sydney. http://sydney.edu.au/china_studies_centre/china_express/issue_4/features/Development-of-clinical-pharmacy-services-in-China.shtml. Accessed 27 Feb 2016.
Penm J, Moles R, Wang H, Li Y, Chaar B. Factors affecting the implementation of clinical pharmacy services in China. Qual Health Res. 2014;24(3):345–56.
Article
PubMed
Google Scholar
Penm J, Chaar B, Rose G, Moles R. Pharmacists’ influences on prescribing: Validating a clinical pharmacy services survey in the Western Pacific Region. Res Social Adm Pharm. 2015;11(1):63–73.
Article
PubMed
Google Scholar
Bao L, Wang Y, Shang T, Ren X, Ma R. A novel clinical pharmacy management system in improving the rational drug use in department of general surgery. Indian J Pharm Sci. 2013;75(1):11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.
Article
PubMed
Google Scholar
Shaanxi - Wikipedia, the free encyclopedia. http://en.wikipedia.org/wiki/Shaanxi. Accessed 27 Feb 2016.
Fang Y, Wagner AK, Yang S, et al. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Lancet Glob Health. 2013;1(4):e227–37.
Article
PubMed
Google Scholar
Iacobucci D, Duhachek A. Advancing alpha: Measuring reliability with confidence. J Consum Psychol. 2003;13(4):478–87.
Article
Google Scholar
Radhakrishna RB. Tips for developing and testing questionnaires/instruments. J Ext. 2007;45(1):1–4.
Google Scholar
Sawalha AF. A descriptive study of self-medication practices among Palestinian medical and nonmedical university students. Res Social Adm Pharm. 2008;4(2):164–72.
Article
PubMed
Google Scholar
Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China’s huge and complex health-care reforms. Lancet. 2012;379(9818):833–42.
Article
PubMed
Google Scholar
Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet. 2012;379(9818):805–14.
Article
PubMed
Google Scholar
World Health Organization. How to develop a National Essential Medicines List. Agenda item for the 18th WHO Expert Committee on the Selection and Use of Essential Medicines. http://www.who.int/selection_medicines/committees/expert/18/How_to_developNEML_agenda_paper.pdf. Accessed 5 Aug, 2015.
China Food and Drug Administration. Notice on Issuing “National Essential medicine list management approach (Interim)”. http://www.sda.gov.cn/WS01/CL0056/40754.html. Accessed 5 Aug, 2015.
Dixit R, Vinay M, Jayasree T, Ubedulla S, Manohar VS, Chandrasekhar N. Availability of essential medicines: A primary health care perspective. Indian J Pharmacol. 2011;43(5):599.
Article
PubMed
PubMed Central
Google Scholar
Schouten EJ, Jahn A, Ben-Smith A, et al. Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc. 2011;14 Suppl 1:S4.
Article
PubMed
PubMed Central
Google Scholar
Penfold S, Shamba D, Hanson C, et al. Staff experiences of providing maternity services in rural southern Tanzania–a focus on equipment, drug and supply issues. BMC Health Serv Res. 2013;13(1):61.
Article
PubMed
PubMed Central
Google Scholar
Tetteh E. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines. Res Social Adm Pharm. 2009;5(3):286–97.
Article
PubMed
Google Scholar
Zhou XD, Li L, Hesketh T. Health system reform in rural China: Voices of health workers and service-users. Soc Sci Med. 2014;117:134–41.
Article
PubMed
Google Scholar
Zhang X, Xiong Y, Ye J, Deng Z, Zhang X. Analysis of government investment in primary healthcare institutions to promote equity during the three-year health reform program in China. BMC Health Serv Res. 2013;13(1):114.
Article
PubMed
PubMed Central
Google Scholar
World Health Organization. Equitable Access to Essential Medicines: A Framework for Collective Action-WHO Policy Perspectives on Medicines, No. 8. Geneva: WHO; 2004.
Google Scholar